Subscribe

Acute Myeloid Leukemia or High-Risk Myelodysplasia | Risk Factors for Acute Pulmonary Failure During Chemo

Purpose:

To determine the risk for acute pulmonary failure developing in a patient undergoing induction chemotherapy for AML or myelodysplasia.

Specialty:

Hematology Oncology
Pulmonology & Critical Care
Clinical Pharmacology & Toxicology

Objective:

risk factors, adverse effects

ICD-10:

T45.1

Description:

Al Ameri at al identified risk factors for acute pulmonary failure during remission induction chemotherapy for acute myeloid leukemia (AML) or high-risk myelodysplasia. These can help to identify a patient who may benefit from closer monitoring and preventive measures during and after therapy. The authors are from the University of Texas M.D. Anderson Cancer Center.

To read more or access our algorithms and calculators, please log in or register.

RECENT TWEETS

medal descover
medal iphone